These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29515570)

  • 1. Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.
    Fonseca W; Lukacs NW; Ptaschinski C
    Front Immunol; 2018; 9():226. PubMed ID: 29515570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.
    San-Juan-Vergara H; Peeples ME
    Immunol Allergy Clin North Am; 2019 Aug; 39(3):321-334. PubMed ID: 31284923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic epidemiology and immunopathology of RSV in children.
    Handforth J; Friedland JS; Sharland M
    Paediatr Respir Rev; 2000 Sep; 1(3):210-4. PubMed ID: 12531081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human genetics and respiratory syncytial virus disease: current findings and future approaches.
    Choi EH; Lee HJ; Chanock SJ
    Curr Top Microbiol Immunol; 2013; 372():121-37. PubMed ID: 24362687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis.
    Piedra FA; Mei M; Avadhanula V; Mehta R; Aideyan L; Garofalo RP; Piedra PA
    PLoS One; 2017; 12(3):e0172953. PubMed ID: 28267794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and epidemiologic features of respiratory syncytial virus.
    Hall CB; Simőes EA; Anderson LJ
    Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a causal relationship between respiratory syncytial virus infection and asthma.
    Wu P; Hartert TV
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):731-45. PubMed ID: 21905783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
    Nokes DJ; Okiro EA; Ngama M; Ochola R; White LJ; Scott PD; English M; Cane PA; Medley GF
    Clin Infect Dis; 2008 Jan; 46(1):50-7. PubMed ID: 18171213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review.
    Öner D; Drysdale SB; McPherson C; Lin GL; Janet S; Broad J; Pollard AJ; Aerssens J;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S648-S657. PubMed ID: 32794555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune responses in respiratory syncytial virus infections.
    Krishnan S; Halonen M; Welliver RC
    Viral Immunol; 2004; 17(2):220-33. PubMed ID: 15279701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.
    Moe N; Krokstad S; Stenseng IH; Christensen A; Skanke LH; Risnes KR; Nordbø SA; Døllner H
    PLoS One; 2017; 12(1):e0170200. PubMed ID: 28095451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in and the potential of vaccines for respiratory syncytial virus.
    Jorquera PA; Oakley KE; Tripp RA
    Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases.
    Malinczak CA; Lukacs NW; Fonseca W
    Viruses; 2020 May; 12(5):. PubMed ID: 32375305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity.
    Anderson J; Do LAH; Wurzel D; Quan Toh Z; Mulholland K; Pellicci DG; Licciardi PV
    Thorax; 2021 Sep; 76(9):942-950. PubMed ID: 33574121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants.
    High M; Cho HY; Marzec J; Wiltshire T; Verhein KC; Caballero MT; Acosta PL; Ciencewicki J; McCaw ZR; Kobzik L; Miller-DeGraff L; Gladwell W; Peden DB; Serra ME; Shi M; Weinberg C; Suzuki O; Wang X; Bell DA; Polack FP; Kleeberger SR
    EBioMedicine; 2016 Sep; 11():73-84. PubMed ID: 27554839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
    Farrag MA; Almajhdi FN
    Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central Role of the NF-κB Pathway in the
    Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of respiratory syncytial virus in the United States.
    Robinson RF
    Am J Health Syst Pharm; 2008 Dec; 65(23 Suppl 8):S3-6. PubMed ID: 19020201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.